Addressing the Risks of Chemo-Induced Myelosuppression in SCLC
Playback speed
10 seconds
Trilaciclib and the Economic Value of Multilineage Myeloprotection From Chemo-Induced Myelosuppression in ES-SCLC Treated With 1L Chemo
639 views
June 6, 2022
Comments 0
Login to view comments.
Click here to Login